Johnson & Johnson’s (NYSE:JNJ) latest earnings statement reveals deep holes in profits due to costs associated with product liability charges and legal settlements in 4th quarter and full year of 2011.
The company posted $65.03 billion in sales for 2011, a 5.6% increase from the $61.59 billion sold in 2010.